| View |
|
DRP-14520
|
Cloxacillin
|
Cloxamed 500
|
500mg
|
Powder For Injection (IM/IV)
|
-
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
28 September 2023
|
28 September 2028
|
| View |
|
DRP-14512
|
Tamsulosin Hydrochloride
|
Tamdome
|
400 mcg
|
Prolonged-Release Capsule
|
-
|
Fredun Pharmaceuticals Limited
|
India
|
Initial
|
26 September 2023
|
26 September 2028
|
| View |
|
DRP-14522
|
Salbutamol (as sulfate)
|
Ventact
|
1 mg/mL (2.5 mg/2.5 mL)
|
Solution for Nebulization
|
-
|
BML Parenteral Drugs
|
India
|
Initial
|
29 September 2023
|
29 September 2028
|
| View |
|
DRP-14514
|
Gemcitabine (as hydrochloride)
|
Gemlife-200
|
200 mg
|
Lyophilized Powder for Solution for I.V.
Infusion
|
-
|
ADMAC Lifesciences
|
India
|
Initial
|
27 September 2023
|
27 September 2028
|
| View |
|
DR-XY48887
|
Ephedrine hydrochloride
|
Epidrex
|
30 mg/mL
|
Solution for Injection (IM/IV)
|
-
|
Pharmaniaga Lifesciences Sdn. Bhd
|
Malaysia
|
Initial
|
28 September 2023
|
28 September 2028
|
| View |
|
DR-XY48807
|
Apixaban
|
Xagulant 5
|
5 mg
|
Film-Coated Tablet
|
Antithrombotic Agent
|
Mylan Laboratories Limited.
|
India
|
Initial
|
07 July 2023
|
07 July 2028
|
| View |
|
DR-XY48806
|
Apixaban
|
Xagulant 2.5
|
2.5 mg
|
Film-Coated Tablet
|
Direct factor Xa Inhibitor
|
Mylan Laboratories Limited
|
India
|
initial
|
07 July 2023
|
07 July 2028
|
| View |
|
DRP-9671
|
Etoricoxib
|
None
|
60mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9670
|
Etoricoxib
|
None
|
90mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-9669
|
Etoricoxib
|
None
|
120mg
|
Film-Coated Tablet
|
-
|
Mankind Pharma Limited (Unit II)
|
India
|
Initial
|
28 April 2021
|
28 April 2026
|
| View |
|
DRP-11514
|
Clopidogrel (as bisulfate)
|
Khrizvix
|
75mg
|
Film-Coated Tablet
|
Antithrombotic (Platelet Aggregation Inhibitor)
|
Fredun Pharmaceuticals Ltd.
|
India
|
Initial
|
30 March 2022
|
30 March 2027
|
| View |
|
DRP-4355-04
|
Clindamycin(as phosphate)
|
Clintam
|
150 mg/mL (600 mg/4 mL)
|
Solution for Injection(I.M./I.V.)
|
Antibacterial(Lincosamide)
|
United Biotech Pvt. Ltd.
|
India
|
Renewal
|
11 September 2023
|
28 September 2027
|
| View |
|
VR-NM0005(FOR EXPORT ONLY)
|
Bayopet Herbal Hair Grower Shampoo
|
Bayopet Herbal Hair (Aloe Vera with Balsam Scent)
|
N/A
|
Dog Shampoo
|
-
|
Marklene Fabricate Corporation
|
Philippines
|
Initial [Vet.]
|
01 June 2021
|
01 June 2026
|
| View |
|
DRP-5310-07
|
Cyclophosphamide
|
Sykloget
|
1 g
|
Powder for Injection (IV)
|
Antineoplastic (Cell Cycle-Nonspecific Agent)
|
Getwell Pharmaceuticals
|
India
|
Renewal
|
16 February 2024
|
28 May 2029
|
| View |
|
DRP-11565-01
|
Propofol
|
Qprofol
|
10 mg/mL (200 mg/ 20 mL)
|
Emulsion for Intravenous Infusion
|
-
|
Aspiro Pharma Limited
|
India
|
-
|
22 March 2023
|
30 March 2027
|
| View |
|
DRP-10929-18
|
Norepinephrine (as bitartrate)
|
Vaxiprin
|
1 mg/mL (4 mg/4 mL)
|
Solution for Injection (IV)
|
-
|
Makcur Laboratories Limited
|
India
|
-
|
31 March 2023
|
31 January 2027
|
| View |
|
DRP-5335-08
|
Cyclophosphamide
|
Sykloget
|
500 mg
|
Powder for I.V. Injection
|
Antineoplastic
|
Getwell Pharmaceuticals
|
India
|
Renewal
|
29 February 2024
|
10 January 2029
|
| View |
|
DRP-11847-05
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Sitagard-M
|
50 mg/ 1 g
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
11 September 2023
|
10 May 2027
|
| View |
|
DRP-11848-06
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Sitagard-M
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
29 September 2023
|
10 May 2027
|
| View |
|
DR-XY6423
|
Risperidone
|
None
|
2 mg
|
Film-coated Tablet
|
Antipsychotic
|
Micro Labs Limited
|
India
|
Renewal
|
11 September 2023
|
20 September 2028
|